Literature DB >> 33331631

Prognostic significance of aortic valve calcium in relation to coronary artery calcification for long-term, cause-specific mortality: results from the CAC Consortium.

Donghee Han1, Rhanderson Cordoso2, Seamus Whelton2, Alan Rozanski3, Matthew J Budoff4, Michael D Miedema5, Khurram Nasir6, Leslee J Shaw7, John A Rumberger8, Heidi Gransar1, Zeina Dardari2, Roger S Blumenthal2, Michael J Blaha2, Daniel S Berman1.   

Abstract

AIMS: Aortic valve calcification (AVC) has been shown to be associated with increased cardiovascular disease (CVD) risk; however, whether this is independent of traditional risk factors and coronary artery calcification (CAC) remains unclear. METHODS AND
RESULTS: From the multicentre CAC Consortium database, 10 007 patients (mean 55.8±11.7 years, 64% male) with concomitant CAC and AVC scoring were included in the current analysis. AVC score was quantified using the Agatston score method and categorized as 0, 1-99, and ≥100. The endpoints were all-cause, CVD, and coronary heart disease (CHD) deaths. AVC (AVC>0) was observed in 1397 (14%) patients. During a median 7.8 (interquartile range: 4.7-10.6) years of study follow-up, 511 (5.1%) deaths occurred; 179 (35%) were CVD deaths, and 101 (19.8%) were CHD deaths. A significant interaction between CAC and AVC for mortality was observed (P<0.001). The incidence of mortality events increased with higher AVC; however, AVC ≥100 was not independently associated with all-cause, CVD, and CHD deaths after adjusting for CVD risk factors and CAC (P=0.192, 0.063, and 0.206, respectively). When further stratified by CAC<100 or ≥100, AVC ≥100 was an independent predictor of all-cause and CVD deaths only in patients with CAC <100, after adjusting for CVD risk factors and CAC [hazard ratio (HR): 1.93, 95% confidence interval (CI): 1.14-3.27; P=0.013 and HR: 2.71, 95% CI: 1.15-6.34; P=0.022, respectively].
CONCLUSION: Although the overall prognostic significance of AVC was attenuated after accounting for CAC, high AVC was independently associated with all-cause and CVD deaths in patients with low coronary atherosclerosis burden. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  aortic valve sclerosis; cardiovascular mortality; computed tomography; coronary artery calcium; prognosis

Mesh:

Substances:

Year:  2021        PMID: 33331631      PMCID: PMC8527330          DOI: 10.1093/ehjci/jeaa336

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  19 in total

1.  Reproducibility of electron-beam CT measures of aortic valve calcification.

Authors:  Matthew J Budoff; Songshou Mao; Junichiro Takasu; David M Shavelle; Xue-Qiao Zhao; Kevin D O'Brien
Journal:  Acad Radiol       Date:  2002-10       Impact factor: 3.173

Review 2.  Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies.

Authors:  Rosario V Freeman; Catherine M Otto
Journal:  Circulation       Date:  2005-06-21       Impact factor: 29.690

3.  CAC-DRS: Coronary Artery Calcium Data and Reporting System. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT).

Authors:  Harvey S Hecht; Michael J Blaha; Ella A Kazerooni; Ricardo C Cury; Matt Budoff; Jonathon Leipsic; Leslee Shaw
Journal:  J Cardiovasc Comput Tomogr       Date:  2018-03-30

4.  Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.

Authors:  B F Stewart; D Siscovick; B K Lind; J M Gardin; J S Gottdiener; V E Smith; D W Kitzman; C M Otto
Journal:  J Am Coll Cardiol       Date:  1997-03-01       Impact factor: 24.094

Review 5.  Aortic-valve stenosis--from patients at risk to severe valve obstruction.

Authors:  Catherine M Otto; Bernard Prendergast
Journal:  N Engl J Med       Date:  2014-08-21       Impact factor: 91.245

6.  Relation of aortic valve calcium detected by cardiac computed tomography to all-cause mortality.

Authors:  Michael J Blaha; Matthew J Budoff; Juan J Rivera; Atif N Khan; Raul D Santos; Leslee J Shaw; Paolo Raggi; Daniel Berman; John A Rumberger; Roger S Blumenthal; Khurram Nasir
Journal:  Am J Cardiol       Date:  2010-11-04       Impact factor: 2.778

7.  Aortic valve calcification: determinants and progression in the population.

Authors:  David Messika-Zeitoun; Lawrence F Bielak; Patricia A Peyser; Patrick F Sheedy; Stephen T Turner; Vuyisile T Nkomo; Jerome F Breen; Joseph Maalouf; Christopher Scott; A Jamil Tajik; Maurice Enriquez-Sarano
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-12-21       Impact factor: 8.311

8.  Aortic valve calcium independently predicts coronary and cardiovascular events in a primary prevention population.

Authors:  David S Owens; Matthew J Budoff; Ronit Katz; Junichiro Takasu; David M Shavelle; J Jeffrey Carr; Susan R Heckbert; Catherine M Otto; Jeffrey L Probstfield; Richard A Kronmal; Kevin D O'Brien
Journal:  JACC Cardiovasc Imaging       Date:  2012-06

9.  Computed Tomography Aortic Valve Calcium Scoring in Patients With Aortic Stenosis.

Authors:  Tania Pawade; Marie-Annick Clavel; Christophe Tribouilloy; Julien Dreyfus; Tiffany Mathieu; Lionel Tastet; Cedric Renard; Mesut Gun; William Steven Arthur Jenkins; Laurent Macron; Jacob W Sechrist; Joan M Lacomis; Virginia Nguyen; Laura Galian Gay; Hug Cuéllar Calabria; Ioannis Ntalas; Timothy Robert Graham Cartlidge; Bernard Prendergast; Ronak Rajani; Arturo Evangelista; João L Cavalcante; David E Newby; Philippe Pibarot; David Messika Zeitoun; Marc R Dweck
Journal:  Circ Cardiovasc Imaging       Date:  2018-03       Impact factor: 7.792

10.  2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

View more
  5 in total

1.  Long-Term Prognostic Implications and Role of Further Testing in Adults Aged ≤55 Years With a Coronary Calcium Score of Zero (from the Multi-Ethnic Study of Atherosclerosis).

Authors:  Miguel Cainzos-Achirica; Isaac Acquah; Zeina Dardari; Reed Mszar; Philip Greenland; Ron Blankstein; Marcio Bittencourt; Sanjay Rajagopalan; Sadeer G Al-Kindi; Joseph F Polak; Roger S Blumenthal; Michael J Blaha; Khurram Nasir
Journal:  Am J Cardiol       Date:  2021-12-15       Impact factor: 2.778

2.  Diagnostic and Prognostic Performance of Aortic Valve Calcium Score with Cardiac CT for Aortic Stenosis: A Meta-Analysis.

Authors:  Tom Kai Ming Wang; Scott D Flamm; Paul Schoenhagen; Brian P Griffin; L Leonardo Rodriguez; Richard A Grimm; Bo Xu
Journal:  Radiol Cardiothorac Imaging       Date:  2021-08-26

Review 3.  Extra-coronary Calcification and Cardiovascular Events: What Do We Know and Where Are We Heading?

Authors:  Dixitha Anugula; Rhanderson Cardoso; Gowtham R Grandhi; Ron Blankstein; Khurram Nasir; Mouaz Al-Mallah; Dipan J Shah; Miguel Cainzos-Achirica
Journal:  Curr Atheroscler Rep       Date:  2022-08-30       Impact factor: 5.967

Review 4.  Role of Extracellular Vesicles as Potential Diagnostic and/or Therapeutic Biomarkers in Chronic Cardiovascular Diseases.

Authors:  Jose Luis Martin-Ventura; Carmen Roncal; Josune Orbe; Luis Miguel Blanco-Colio
Journal:  Front Cell Dev Biol       Date:  2022-01-26

5.  Risk Markers for Limited Coronary Artery Calcium in Persons With Significant Aortic Valve Calcium (From the Multi-ethnic Study of Atherosclerosis).

Authors:  Alexander C Razavi; Rhanderson Cardoso; Omar Dzaye; Matthew Budoff; George Thanassoulis; Wendy S Post; Sanjiv Shah; Daniel S Berman; Khurram Nasir; Michael J Blaha; Seamus P Whelton
Journal:  Am J Cardiol       Date:  2021-07-27       Impact factor: 3.133

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.